Acitretin (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Acitretin drug offered from Actavis Pharma, Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Acitretin
SUBSTANCE NAME: ACITRETIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Retinoid [EPC],Retinoids [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2016-01-04
END MARKETING DATE: 0000-00-00


Acitretin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAcitretin from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2016-01-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-2263_74b34983-888e-418b-924c-2ffe2bc68065
PRODUCT NDC: 0591-2263
APPLICATION NUMBER: ANDA202552

Other ACITRETIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Acitretin
AvKARE, Inc.ACITRETIN
Impax GenericsAcitretin
Mylan Pharmaceuticals Inc.Acitretin
Prasco LaboratoriesACITRETIN
Sigmapharm Laboratories, LLCACITRETIN
Stiefel Laboratories IncSORIATANE
Teva Pharmaceuticals USA, Inc.Acitretin